Start your 3-day free trial
Sign up to experience all premium features at no cost.
*Available only to new users. Each user is limited to one trial.


To design an experiment plan with AI, begin with the decision you need to make, translate it into a falsifiable hypothesis, and supply verified constraints about the population, treatment, outcomes, assignment, and data. Use AI to structure the protocol and expose omissions, while qualified people retain control of statistical choices, ethics, execution, and interpretation.
The method fits non-clinical product, service, process, and operational experiments. It complements the broader responsible AI workflow, but it does not authorize clinical research, human-subject research, or experiments that require ethics, legal, safety, or regulatory approval.
Key Takeaways
- Write the decision and falsifiable hypothesis before selecting metrics or methods.
- Define the experimental unit, population, treatment, control, assignment, and interference risks.
- Preselect one primary outcome, supporting outcomes, guardrails, and data-quality rules.
- Let a qualified analyst own power, sample size, multiplicity, stopping, and analysis choices.
- Record deviations and analyze with reproducible tools rather than asking AI for a verdict.
An experiment plan is a versioned protocol that connects a decision to a testable comparison. NIST describes experiment design as a systematic, rigorous approach to engineering problem solving and lays out a sequence from objectives and variables through design, execution, analysis, and conclusions.[1][2] The important word is systematic: a polished hypothesis alone is not a design.
Use a structured header and protocol table:
| Field | What to record |
|---|---|
| Experiment ID and version | Stable identity and change history |
| Decision | Action the evidence will inform |
| Hypothesis | Falsifiable claim stated before observation |
| Unit and population | What is assigned and to whom results may generalize |
| Eligibility | Inclusion, exclusion, recruitment, and sampling rules |
| Treatment and control | Exact experiences, baseline, and forbidden differences |
| Outcomes | Primary, secondary, diagnostic, and guardrail measures |
| Assignment | Randomization or allocation method and stratification |
| Sample rationale | Power, precision, assumptions, and responsible analyst |
| Analysis plan | Estimand, model, missing-data rule, and multiplicity handling |
| Stopping rule | Duration, information threshold, safety stop, and authority |
| Data controls | Instrumentation, validation, access, retention, and privacy |
| Decision rule | How reviewed evidence informs the named decision |
| Approval | Statistical, domain, ethics, privacy, and operational sign-off |
This record prevents convenient changes after results become visible. It also makes it possible to distinguish a design flaw from an unexpected result.
Write one operational decision: for example, whether to roll out a revised onboarding sequence to a defined customer segment. State who owns that decision, which evidence would change it, and what remains outside the experiment.
Then write a falsifiable hypothesis. “The new flow is better” is not testable. “For eligible new users, the revised flow changes seven-day completion of the defined onboarding milestone relative to the current flow” identifies a population, comparison, outcome, and window without pretending to know the direction or size.
Do not turn uncertainty into a scenario analysis. Scenario analysis explores plausible conditions and responses; an experiment deliberately varies a factor and measures outcomes under a defined design. Both can support a decision, but their evidence has different meaning.
Name the experimental unit: user, account, team, store, device, session, batch, or another entity. The unit must match how treatment is assigned. Assigning by account while analyzing every session as independent can overstate how much information the experiment contains.
Define the target population, sampling frame, eligibility rules, exclusions, geography, time window, and expected sources of interference. Ask whether one unit can affect another, whether a person can see both variants, whether shared devices or teams create contamination, and whether seasonal events change the population during the run.
Record who may be exposed and what consent, notice, policy, safety, or ethics review applies. Experiments involving health, protected groups, employees, children, consequential allocation, or human-subject research require qualified institutional review. A general AI tutorial cannot decide whether an activity is exempt or ethically acceptable.
Describe what each group receives, when exposure starts, how long it lasts, and which elements must remain equal. Version the content, code, configuration, eligibility query, and delivery mechanism. A label such as “variant B” is useless if the experience changes halfway through the test.
Use an exposure contract:
| Item | Synthetic example |
|---|---|
| Control | Existing three-step help flow, version H-17 |
| Treatment | Same flow with reordered explanations, version H-18 |
| Assignment unit | Account |
| Exposure event | First eligible flow start after allocation |
| Cross-over | Not allowed during the analysis window |
| Concurrent changes | No pricing, eligibility, or notification changes |
| Rollback | Restore H-17 for new exposures; preserve allocation log |
Keep the example synthetic. Do not upload customer-level histories, employee records, medical data, credentials, or unreleased commercial details to an AI tool.
Select one primary outcome that best answers the decision. Define its numerator, denominator, unit, attribution window, exclusions, time zone, and handling of repeated events. Secondary outcomes explain trade-offs; diagnostic measures test whether implementation behaved as expected; guardrails detect unacceptable harm.
Avoid a large menu of interchangeable primary metrics. If reviewers can choose whichever metric looks favorable after the run, the decision rule is no longer stable. A qualified analyst should define how multiple outcomes and repeated looks will be handled.
Data-quality checks belong beside business outcomes:
If the outcome depends on a survey, establish the instrument separately through a controlled survey-question workflow. Do not change questions, scale labels, or sampling rules after seeing early results.
NIST's design-selection guidance shows that the correct design depends on the objective, factors, constraints, resources, and analysis needs.[3] AI may list candidate designs, but it does not know the organization's loss function, dependence structure, plausible effect, variance, or operational constraints unless those facts are supplied and checked.
The responsible analyst should specify:
Do not ask AI to invent a baseline conversion rate, standard deviation, minimum detectable effect, or acceptable false-positive rate. If those inputs are unknown, the plan should say what pilot, historical analysis, or expert judgment will supply them.
Describe how units enter the allocation, which randomization mechanism is used, whether it is deterministic and reproducible, and who can inspect assignments. If randomization is impossible, name the quasi-experimental assumptions and the specialist responsible for reviewing them.
Blinding can reduce some forms of bias, but it is not always feasible. State which participants, operators, analysts, or decision-makers are blinded, when unblinding occurs, and which emergency conditions permit it. Never claim a design is blinded when labels, UI differences, logs, or operational procedures reveal allocation.
Before launch, run an implementation rehearsal with synthetic units. Verify eligibility, assignment persistence, exposure events, treatment version, metric computation, exclusion rules, access permissions, and rollback. A project plan can coordinate delivery tasks, but it does not replace the experiment protocol.
Provide a sanitized evidence packet and request a gap-focused draft:
Organize the supplied experiment facts into the required protocol fields.
Preserve IDs, definitions, versions, owners, and source references exactly.
Do not invent hypotheses, baselines, effect sizes, variance, sample sizes,
power, significance levels, outcomes, stopping rules, ethical approvals,
or decision thresholds. Mark missing facts as [VERIFY].
Separate confirmed facts, analyst decisions, and optional suggestions.
Return contradictions and review questions before drafting prose.
Ask the model to trace every populated field to an evidence ID. It may improve clarity, compare terminology, or identify an omitted failure mode. It must not compute a sample size from guessed inputs or declare that the design supports a causal conclusion.
NIST's generative-AI profile identifies confabulation, privacy, information integrity, and human-AI configuration as material risks.[4] That makes provenance and role separation part of the experiment design, not an optional editorial cleanup.
Write the planned analysis before outcome access. Specify datasets, transformations, exclusions, estimand, model, uncertainty measure, diagnostic checks, and output tables. Use deterministic statistical software or reviewed code for calculations; AI can explain code or flag mismatches, but numerical results must be reproducible from the frozen data and analysis version.
Define when the experiment ends. Calendar duration alone may be insufficient if traffic or data latency varies. State minimum exposure, required information, maximum duration, safety and guardrail stops, operational stops, and who may stop early. If repeated analyses are planned, account for them in the approved statistical method.
The decision rule should not collapse evidence into “significant means ship.” It should consider effect size, uncertainty, guardrails, external validity, implementation quality, costs, and reversibility. Record who interprets these factors and which outcomes trigger more research rather than rollout.
Freeze the approved plan and version all implementation artifacts. During the run, record outages, instrumentation changes, eligibility bugs, cross-over, delayed events, manual interventions, and any early access to outcome data. Do not quietly edit the original protocol to match what happened.
For every deviation, capture timestamp, affected units or period, detected-by, immediate response, potential bias, owner, and disposition. A serious deviation may invalidate the planned analysis; that judgment belongs to the responsible analyst and domain reviewers.
Keep monitoring roles separate. Operators may watch safety and system health without browsing outcome slices that could influence treatment or duration. Access should follow least privilege, especially when participant-level data is sensitive.
Run the frozen analysis against the frozen dataset, retain code and environment information, and verify output independently. Report estimates with uncertainty, missingness, exclusions, deviations, guardrail behavior, and limitations. Label unplanned subgroup or metric exploration as exploratory.
Use a second reviewer to challenge data quality, assumptions, multiple testing, practical significance, and generalizability. Fact-check AI-assisted explanations against the numeric output and protocol; do not let a fluent narrative override contradictory tables.
The decision owner records whether to adopt, reject, modify, repeat, or gather more evidence. Preserve the protocol, analysis, deviations, reviewed result, and decision as separate artifacts. This makes later learning possible without rewriting the study history.
No. A project plan coordinates work, owners, dependencies, and dates. An experiment plan defines a comparison that can answer a hypothesis, including assignment, outcomes, analysis, stopping, and interpretation.
AI can help implement a reviewed formula or explain required inputs. A qualified analyst must choose the effect, variance, power, error rate, dependence assumptions, and method; invented inputs produce a precise but unsupported answer.
No, but causal interpretation becomes more dependent on assumptions when allocation is not randomized. Document the reason, alternative design, likely confounding, analysis method, and specialist review.
Usually one clearly defined primary outcome keeps the decision interpretable. If several are necessary, specify their roles and multiplicity handling before results are available.
A secondary outcome adds context about benefits or mechanisms. A guardrail represents harm or degradation that may block or reverse rollout even when the primary outcome improves.
Only under predeclared safety, operational, futility, efficacy, or information rules with named authority and an appropriate statistical method. A surprising dashboard movement or AI recommendation is not an adequate stopping rule.
Use approved tools, minimum necessary access, de-identification where appropriate, and documented retention. Prefer aggregated or synthetic material for drafting; sensitive individual records should not be uploaded merely for convenience.
No. The decision also considers effect size, uncertainty, guardrails, implementation quality, external validity, costs, ethics, and reversibility. The accountable owner records that judgment.
This article provides general information, not statistical, clinical, ethics, or legal advice. Clinical or human-subject research requires qualified statistical and institutional review.
Sources checked 4 September 2026.
Sign up to experience all premium features at no cost.
*Available only to new users. Each user is limited to one trial.